Mrna Vaccine News

Moderna and Merck announced that a new personalized mRNA vaccine significantly reduced the risk of melanoma recurrence and spread in a late-stage trial, marking

Moderna and Merck's personalized mRNA cancer vaccine has met its primary goals in a Phase 3 trial for high-risk melanoma, marking a significant breakthrough and

Moderna and Merck have announced that their experimental mRNA vaccine has shown success in preventing the return and spread of melanoma in high-risk patients. T

Newly released text messages from January 2021 show Dr. Anthony Fauci, Dr. Rochelle Walensky, and Dr. Vivek Murthy privately discussing concerns about COVID-19

Health Canada has authorized Moderna to begin a clinical trial for an mRNA vaccine targeting the Bundibugyo form of the Ebola virus, which is currently causing